✓
Open
27 Apr 2016
✓
Close
29 Apr 2016
3
Allotment
—
✓
Listing
Mon, May 9, 2016
Price Band
₹420 to ₹446
Issue Size
1,07,44,708 shares (agg. up to ₹479 Cr)
Lot Size
33 Shares
Listing Date
Mon, May 9, 2016
✦ AI Insight
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 52.27x |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Dr.Lal PathLabs Ltd. | Mainboard | ₹631.91 Cr | ₹550 | null | ₹825.00 | +50.00% | ₹1,687.40 (-2.76%) |
| Tejnaksh Healthcare Ltd. | SME | ₹2.43 Cr | ₹80 | null | ₹76.00 | -5.00% | ₹13.96 (+0.43%) |
About Thyrocare Technologies IPO
Incorporated in 2000, Thyrocare Technologie Ltd is one of the leading pan-India diagnostic chains and conduct an array of medical diagnostic tests and profiles of tests that helps in early detection and management of disorders and diseases. They are India's first fully automated diagnostic laboratory having its strong presence in more than 2000 cities / towns in India and internationally. As of November 30, 2015, they offered 192 tests and 54 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.Their laboratory process over 30,000 sample and above 1 lakh investigations every day. Their profiles of tests include 17 profiles of tests administered under their 'Aarogyam' brand. Through wholly owned subsidiary, NHL, they operate a network of molecular imaging centers in New Delhi, Navi Mumbai and Hyderabad, focused on early and effective cancer monitoring.+ Read More
Contact Details
Thyrocare Technologies Ltd. AddressD/37-1, TTC Industrial AreaMIDC TurbheNavi Mumbai, Maharashtra, 400703+(91 22) 2762 2762ramjee.d@thyrocare.comVisit Website